NRG1 and Alzheimer disease: In the retrospective study by Mouton-Liger et al., which included a total of 162 subjects, NRG1 levels in the CSF of AD patients were significantly increased compared to controls and subjects with other neurological disorders, underlining the specificity of NRG1 to signal synaptic impairment typical of AD [88].